Related Tags >> Mergers and Acquisitions Genentech Eyetech Macugen

macular degeneration News

Most Popular macular degeneration Story

QLT stock rockets as acne drug is cleared for takeoff

March 18, 2008 — 7:59am ET

Shares of QLT rocketed up 55 percent in a tense market yesterday after the biotech finished a lengthy task in persuading the FDA that a blood test should not be required before doctors prescribe its... Read more...

Latest Headlines

QLT stock rockets as acne drug is cleared for takeoff
March 18, 2008
Taligen raises a whopping $65M
February 1, 2008
Press Release: Genaera Corporation Terminates Evizon Clinical Program and Restructures
January 4, 2007
The best (and worst) biotech stocks of 2006
December 1, 2006
VC: Cerenis garners $53.5M in second round
November 15, 2006
SPOTLIGHT: Cleveland Clinic's top 10
November 9, 2006
New biotech arrival gains $10M in venture funds
November 1, 2006
California institute outlines stem-cell strategy
October 4, 2006
DEALS: Merck KGaA buys Serono for $13.3B
September 27, 2006
ALSO NOTED: Barr raises bid on Pliva; Synta touts new data; regulators question Factive rashes;and much more...
September 10, 2006
OSI delays $935M Eyetech deal
November 10, 2005
ALSO NOTED: Altus files $115M IPO; Elan, Biogen find no new PML cases; Genentech discouraging Avastin for macular degeneration;
October 16, 2005
QLT shares drop after eye drug flunks vision-loss trial
September 20, 2005
ALSO NOTED: Ranbaxy gets marketing OK for HIV drug; VaxGen to sell an interest in Celltrion; Isotechnika touts PIII results; Al
September 20, 2005
DEALS: OSI acquires Eyetech
August 31, 2005
OSI to acquire Eyetech for $935M
August 21, 2005
Theragenics lays off workers, restructures development programs
August 10, 2005
Eyetech adopts poison pill
June 8, 2005

Paid Research Reports

More Research Reports >>